Skip to main content

Table 1 Main characteristic of included patients

From: Evaluation of time in therapeutic range in anticoagulated patients: a single-center, retrospective, observational study

Characteristics

Population (N = 377)

Age – years

 

Mean (SD)

71.0 (10.4)

Median (IQR)

72.0 (66–79)

Female sex – no. (%)

153 (40.6)

Previous stroke or transient ischemic attack – no. (%)

56 (14.9)

Heart failure – no. (%)

160 (42.4)

Diabetes mellitus – no. (%)

101 (26.8)

Hypertension - no. (%)

253 (67.1)

Vascular Disease History – no. (%)

122 (32.4)

Indication for anticoagulation

 

Non-valvular AF

273 (72.4)

Valvular AF*

72 (19.1)

Venous thromboembolism

13 (3.4)

Others

19 (5.1)

CHA2DS2-VASc

 

Mean (SD)

3.58 (1.62)

Median (IQR)

3 (2–5)

  1. *Mitral stenosis, severe aortic stenosis, severe mitral regurgitation, biologic prosthetic valves, valve repair. AF: Atrial Fibrillation; IQR: Interquartile Range; SD: Standard Deviation